Literature DB >> 28477291

The effect of complementary private health insurance on the use of health care services.

Astrid Kiil1, Jacob Nielsen Arendt2.   

Abstract

This study estimates the effect of complementary private health insurance (PHI) on the use of health care. The empirical analysis focuses on an institutional setting in which empirical findings are still limited; namely on PHI covering co-payment for treatments that are only partly financed by a universal health care system. The analysis is based on Danish data recently collected specifically for this purpose, which makes identification strategies assuming selection on observables only, and on both observables and unobservables also, both plausible and possible. We find evidence of a substantial positive and significant effect of complementary PHI on the use of prescription medicine and chiropractic care, a smaller but significant effect on dental care, weaker indications of effects for physiotherapy and general practice, and finally that the use of hospital-based outpatient care is largely unaffected. This implies that complementary PHI is generally not simply a marker of a higher propensity to use health care but induces additional use of some health care services over and above what would be used in the absence of such coverage.

Entities:  

Keywords:  Health care utilization; Moral hazard; Parametric estimators; Private health insurance; Propensity score matching; Treatment effects

Mesh:

Year:  2016        PMID: 28477291     DOI: 10.1007/s10754-016-9195-3

Source DB:  PubMed          Journal:  Int J Health Econ Manag        ISSN: 2199-9031


  17 in total

1.  Duplicate coverage and demand for health care. The case of Catalonia.

Authors:  A M Vera-Hernández
Journal:  Health Econ       Date:  1999-11       Impact factor: 3.046

2.  The effect of variable health insurance deductibles on the demand for physician visits.

Authors:  M Schellhorn
Journal:  Health Econ       Date:  2001-07       Impact factor: 3.046

3.  The welfare economics of moral hazard.

Authors:  J A Nyman; R Maude-Griffin
Journal:  Int J Health Care Finance Econ       Date:  2001-03

4.  Explaining income-related inequalities in doctor utilisation in Europe.

Authors:  Eddy van Doorslaer; Xander Koolman; Andrew M Jones
Journal:  Health Econ       Date:  2004-07       Impact factor: 3.046

5.  Does employment-based private health insurance increase the use of covered health care services? A matching estimator approach.

Authors:  Astrid Kiil
Journal:  Int J Health Care Finance Econ       Date:  2012-02-26

6.  Supplemental health insurance and equality of access in Belgium.

Authors:  Erik Schokkaert; Tom Van Ourti; Diana De Graeve; Ann Lecluyse; Carine Van de Voorde
Journal:  Health Econ       Date:  2010-04       Impact factor: 3.046

7.  Higher Education and Health Investments: Does More Schooling Affect Preventive Health Care Use?

Authors:  Jason M Fletcher; David E Frisvold
Journal:  J Hum Cap       Date:  2009

8.  Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market.

Authors:  Amy Finkelstein; Kathleen McGarry
Journal:  Am Econ Rev       Date:  2006-09-01

9.  The Impact of Nearly Universal Insurance Coverage on Health Care Utilization: Evidence from Medicare.

Authors:  David Card; Carlos Dobkin; Nicole Maestas
Journal:  Am Econ Rev       Date:  2008-12

10.  Access to physician services: does supplemental insurance matter? evidence from France.

Authors:  Thomas C Buchmueller; Agnès Couffinhal; Michel Grignon; Marc Perronnin
Journal:  Health Econ       Date:  2004-07       Impact factor: 3.046

View more
  2 in total

1.  Voluntary private health insurance, health-related behaviours and health outcomes: evidence from Russia.

Authors:  Andrey Aistov; Ekaterina Aleksandrova; Christopher J Gerry
Journal:  Eur J Health Econ       Date:  2020-12-23

2.  Moral hazard and selection for voluntary deductibles.

Authors:  Rob J M Alessie; Viola Angelini; Jochen O Mierau; Laura Viluma
Journal:  Health Econ       Date:  2020-07-31       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.